DK165694C - (1h-tetrazol-5-yl)-tetrazolo-(iso)quinoliner eller -oe1,8aanaphthyridiner eller et pharmaceutisk acceptabelt salt deraf - Google Patents

(1h-tetrazol-5-yl)-tetrazolo-(iso)quinoliner eller -oe1,8aanaphthyridiner eller et pharmaceutisk acceptabelt salt deraf

Info

Publication number
DK165694C
DK165694C DK165584A DK165584A DK165694C DK 165694 C DK165694 C DK 165694C DK 165584 A DK165584 A DK 165584A DK 165584 A DK165584 A DK 165584A DK 165694 C DK165694 C DK 165694C
Authority
DK
Denmark
Prior art keywords
tetrazolo
quinolines
tetrazol
iso
acceptable salt
Prior art date
Application number
DK165584A
Other languages
English (en)
Other versions
DK165694B (da
DK165584D0 (da
DK165584A (da
Inventor
Terry L Wright
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK165584D0 publication Critical patent/DK165584D0/da
Publication of DK165584A publication Critical patent/DK165584A/da
Publication of DK165694B publication Critical patent/DK165694B/da
Application granted granted Critical
Publication of DK165694C publication Critical patent/DK165694C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
DK165584A 1983-03-25 1984-03-23 (1h-tetrazol-5-yl)-tetrazolo-(iso)quinoliner eller -oe1,8aanaphthyridiner eller et pharmaceutisk acceptabelt salt deraf DK165694C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/478,964 US4496569A (en) 1983-03-25 1983-03-25 Antiallergic (1H-tetrazol-5-yl)tetrazolo[1,5-a]quinolines and derivatives thereof
US47896483 1983-03-25

Publications (4)

Publication Number Publication Date
DK165584D0 DK165584D0 (da) 1984-03-23
DK165584A DK165584A (da) 1984-09-26
DK165694B DK165694B (da) 1993-01-04
DK165694C true DK165694C (da) 1993-06-07

Family

ID=23902115

Family Applications (1)

Application Number Title Priority Date Filing Date
DK165584A DK165694C (da) 1983-03-25 1984-03-23 (1h-tetrazol-5-yl)-tetrazolo-(iso)quinoliner eller -oe1,8aanaphthyridiner eller et pharmaceutisk acceptabelt salt deraf

Country Status (19)

Country Link
US (1) US4496569A (da)
EP (1) EP0120484B1 (da)
JP (1) JPS59176287A (da)
KR (1) KR900003649B1 (da)
AT (1) ATE26717T1 (da)
AU (1) AU558762B2 (da)
CA (1) CA1252100A (da)
DE (1) DE3463271D1 (da)
DK (1) DK165694C (da)
ES (1) ES530876A0 (da)
GR (1) GR81463B (da)
IE (1) IE57072B1 (da)
IL (1) IL71318A (da)
MX (1) MX9203341A (da)
NO (1) NO161067C (da)
NZ (1) NZ207582A (da)
PH (1) PH20353A (da)
PT (1) PT78288B (da)
ZA (1) ZA842067B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014171A1 (de) * 1990-05-03 1991-11-07 Basf Ag Cyanochinolinverbindungen
AU686761B2 (en) * 1994-03-25 1998-02-12 Merrell Pharmaceuticals Inc. Process for preparing (1H-tetrazol-5-yl)tetrazolo (1,5-a) quinolines and naphthyridines
JP3674407B2 (ja) 1999-09-21 2005-07-20 ヤマハ株式会社 演奏データ編集装置、方法及び記録媒体
EP1668009A1 (en) * 2003-09-26 2006-06-14 Rigel Pharmaceuticals, Inc. Hcv inhibitors and methods of using them
US7569580B2 (en) 2004-06-03 2009-08-04 Rigel Pharmaceuticals, Inc. Heterotricyclic compounds for use as HCV inhibitors
KR101101950B1 (ko) * 2011-11-04 2012-01-02 이동진 왕복 페달식 자전거

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764681A (en) * 1970-07-08 1973-10-09 Lilly Co Eli Certain tetrazolo-(1,5-a) quinoline compounds as fungus control agents
US4035368A (en) * 1975-04-02 1977-07-12 Riker Laboratories, Inc. Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds

Also Published As

Publication number Publication date
EP0120484B1 (en) 1987-04-22
PH20353A (en) 1986-12-04
MX9203341A (es) 1992-08-01
JPS59176287A (ja) 1984-10-05
NZ207582A (en) 1986-10-08
DK165694B (da) 1993-01-04
KR900003649B1 (ko) 1990-05-28
ES8601970A1 (es) 1985-11-01
AU558762B2 (en) 1987-02-05
AU2595384A (en) 1984-09-27
CA1252100A (en) 1989-04-04
DK165584D0 (da) 1984-03-23
JPH0415791B2 (da) 1992-03-19
US4496569A (en) 1985-01-29
PT78288A (en) 1984-04-01
NO161067B (no) 1989-03-20
GR81463B (da) 1984-12-11
ES530876A0 (es) 1985-11-01
PT78288B (en) 1986-04-22
ATE26717T1 (de) 1987-05-15
EP0120484A1 (en) 1984-10-03
ZA842067B (en) 1984-10-31
IE840719L (en) 1984-09-25
DE3463271D1 (en) 1987-05-27
IE57072B1 (en) 1992-04-22
DK165584A (da) 1984-09-26
NO841156L (no) 1984-09-26
IL71318A (en) 1986-11-30
KR840008156A (ko) 1984-12-13
NO161067C (no) 1989-06-28
IL71318A0 (en) 1984-06-29

Similar Documents

Publication Publication Date Title
NL990030I2 (nl) Derivaten en analogen van 2-deoxy-2,3-didehydro-N-acetylneuraminezuur en het gebruik ervan als antivirale middelen.
DE3868308D1 (de) Heterozyklische derivate, verfahren zu deren herstellung und diese enthaltende radiosensibilisierende agenzien und antivirale agenzien.
NO931635D0 (no) Fremgangsmaate for fremstilling av kinazolin-derivater
EP0236140A3 (en) Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
DE3888466D1 (de) 6-Arylaminomethylchinolin-Derivate und ihre Verwendung als Antitumorwirkstoff.
IT8124296A0 (it) Piperidil derivati di composti triazinici macrociclici, aventi attivita' stabilizzante per i polimeri e processi per la loro preparazione.
FI884138A7 (fi) 3,7-diatsabisyklo (3,3,1) nonaaniyhdisteet, menetelmät niiden valmistamiseksi sekä näitä yhdisteitä sisältävät lääkeaineet.
NL189856C (nl) Zuuradditiezout van 2-amino-3-carbethoxyamino-6-(p-fluorbenzylamino)pyridine; werkwijze voor het bereiden daarvan, en farmaceutisch preparaat.
DE3485714D1 (de) (substituierte phenylaliphatische)-isoxazole welche als antivirale mittel verwendbar sind und deren herstellung.
EP0124314A3 (en) Substituted-3H-indeno(1,2-c)pyridazin-3-ones
AU562115B2 (en) Tetrazolyl substituted quinolinones and naphthyridones
AU558762B2 (en) Tetrazole substituted tetrazolo 1,5-a -quinolines
SE8700555D0 (sv) Purine derivatives, their production and medicaments containing them
SE8302751D0 (sv) 2(1h)-pyridinon-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
DE3469295D1 (en) Derivatives of pyridine, pyrazine and pyrimidine and their use as fungicidal agents
ATE41003T1 (de) Tetrazolothienopyridine.
SE8400118D0 (sv) Substituted carboxy-thiazolo(3,2-a)pyrimidine derivatives and process for their preparation
DE3576076D1 (de) (tetrazolyl)thienopyridone.
IL67400A (en) Octahydro-3,7a-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
ZA84482B (en) Agent for separating dissolved and/or undissolved materials
JPS5293779A (en) 5-substituted or non-substituted uracil derivatives and their preparat ion
ATE23332T1 (de) Alpha-phenyl-2-(aza)benzothiazolythioglykolsaeur n und deren derivate.
ATE17718T1 (de) Aza-analoge von aminosaeure-derivaten und ihre verwendung als antihypertensive.
NL191782C (nl) Buitenzwenkdeur voor voertuigen.

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed